The authors also showed significantly higher levels of apelin in obese women with endometrial cancer (243.5 ± 49.2 pg/mL vs. 200.5 ± 52.7 pg/mL), which may indicate the involvement of apelin in the pathomechanism of endometrial cancer development. The gene discussed is APLN; the disease is endometrial cancer.